Active Ingredient(s): Pembrolizumab
FDA Approved: * September 4, 2014
Pharm Company: * MERCK SHARP DOHME
Category: Cancer

Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.[3][5][6][7] It is given by slow injection into a vein.[6] Common side effects include fatigue, musculoskeletal pain, decreased appetite, itchy skin (pruritus), diarrhea,... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Keytruda 25 mg/ml Intravenous Injection, Solution
NDC: 0006-3026
Merck Sharp & Dohme Corp.
Keytruda 50 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0006-3029
Merck Sharp & Dohme Corp.

Popular Topics

Keytruda vs Ippy

I just failed Ippy. Now my oncologist wants to start Keytruda 1/16/15. Those of you who have been on Keytruda for awhile...

Thyroid cancer and KEYTRUDA

I have stage 4 thyroid cancer which has metastasized to my lungs. Although it is slow growing, the cancer will kill me. ...